N Fatima Selected Research

Chromosome Aberrations (Chromosome Abnormalities)

2/2009

Protective effect of liposomal formulation of tuftsin (a naturally occurring tetrapeptide) against cyclophosphamide-induced genotoxicity and oxidative stress in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Fatima Research Topics

Disease

1	Weight Gain 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Inflammation (Inflammations) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2020
1	Carcinoma (Carcinomatosis) 04/2020
1	Neoplasms (Cancer) 04/2020
1	Hemorrhage 07/2014
1	Virus Diseases (Viral Diseases) 07/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2009
1	Body Weight (Weight, Body) 09/2008
1	Hepatitis 04/2001
1	Jaundice (Icterus) 04/2001
1	Liver Diseases (Liver Disease) 04/2001
1	Necrosis 04/2001
1	Tuberculosis (Tuberculoses) 04/2001
1	Pulmonary Tuberculosis 04/2001

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 02/2009 - 04/2001
1	AgarIBA 01/2022
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2022
1	n-hexaneIBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	ethyl acetateIBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	AntioxidantsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	Transcription Factors (Transcription Factor)IBA 04/2020
1	Factor XIII (Coagulation Factor XIII)IBA 07/2014
1	MannansIBA 07/2012
1	OligosaccharidesIBA 07/2012
1	Glucose (Dextrose)FDA LinkGeneric 09/2008
1	LipidsIBA 09/2008
1	AntigensIBA 04/2001
1	Transaminases (Aminotransferases)IBA 04/2001
1	Alkaline PhosphataseIBA 04/2001

Therapy/Procedure

2	Therapeutics 04/2020 - 04/2001
1	Drug Therapy (Chemotherapy) 04/2001